Search results
Research: Perimenopausal women 40% more likely to suffer depression
dpa international via Yahoo News· 2 hours agoPerimenopausal women have a 40% higher risk of suffering depression than those experiencing no...
Woman at greater risk for depression in years leading up to menopause - UPI.com
UPI· 13 minutes agoWomen in the transition period prior to menopause are 40% more likely to experience depression than premenopausal women, according to pooled data from seven studies involving ...
Can Lexapro Cause Weight Loss?
MediaFeed via AOL· 3 hours agoNot only can regular exercise help you to maintain your weight — it can also reduce the severity of depression symptoms by promoting the release of...
Psoriasis and Depression: What’s the Connection?
Verywell Health via Yahoo News· 2 days agoPsoriasis is a chronic skin condition that can affect your mood, and many people with psoriasis experience depression. Here’s what you can do if you feel...
Many children with symptoms of brain injuries and concussions are missing out on vital checks,...
Medical Xpress· 5 days agoThe research, which is published in the journal Brain Injury, also shows that children with symptoms...
May is Mental Health Awareness Month, Live Active El Paso offers resources to the community - KVIA
ABC 7 El Paso· 4 hours agoOne of the main goals is to get rid of the stigma surrounding metal health. Stress, anxiety and ...
Perimenopause may raise risk of one mental health condition by 40%, study finds
KCRA 3 Sacramento· 12 hours agoIn the years leading up to menopause, a person can experience a multitude of symptoms, including...
Perimenopause Brings a Big Boost in Depression Risk
newser· 1 hour agoPerimenopause, a period in which estrogen and progesterone levels fluctuate, is associated with anxiety, mood changes, low self-esteem, memory and concentration issues, hot flashes, sleep problems ...
Women are 40% more likely to experience depression during perimenopause, finds study
Medical Xpress· 16 hours agoDuring this stage, women's estrogen and progesterone levels begin to fluctuate, causing them to...
Lipocine Announces Completion of Dosing in Pivotal Study of Postpartum Depression Candidate, LPCN...
The Herald Journal· 4 hours agoLipocine Inc. (NASDAQ: LPCN), a biopharmaceutical company, today announced that dosing of subjects has been completed in the pivotal pharmacokinetic (PK) study designed to support a New Drug ...
